1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Sex differences in disease progression in Alzheimer patients with different concomitant medications.
2023) 17th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2023)(
- Contribution to conference › Abstract
- 2022
-
Mark
Interaction effect of sex and onset of Alzheimer’s disease—rates of progression and prognosis.
2022) 16th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)(
- Contribution to conference › Abstract
-
Mark
Sex differences between early- and late-onset Alzheimer’s disease.
2022) The Kock Foundation International Symposium on Osteoarthritis & Alzheimer's disease 2022(
- Contribution to conference › Abstract
- 2021
-
Mark
Predictors of mortality in patients with different apolipoprotein E genotypes—a 20-year follow-up of Alzheimer’s disease.
2021) 15th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2021)(
- Contribution to conference › Abstract
- 2020
-
Mark
The interaction effect of sex and apolipoprotein E genotype in Alzheimer’s disease—rates of progression and prognosis.
2020) Advances in Alzheimer's and Parkinson's Therapies (AAT-AD/PD) Focus Meeting 2020(
- Contribution to conference › Abstract
- 2019
-
Mark
Sex differences in predictors of mortality in patients with Alzheimer’s disease – A 20-year follow-up.
2019) 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019)(
- Contribution to conference › Abstract
- 2018
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018(
- Contribution to conference › Abstract
- 2017
-
Mark
The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article